C M Bidwell & Associates LTD Castle Biosciences Inc Transaction History

C M Bidwell & Associates LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$19.47 - $28.49 $1,460 - $2,136	75 New	75 $1,000
Q2 2021 Aug 13, 2021	SELL	$50.07 - $76.78 $13,268 - $20,346	-265 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$58.92 - $97.33 $4,124 - $6,813	-70 Reduced 20.9%	265 $18,000
Q4 2020 Feb 16, 2021	SELL	$43.6 - $73.05 $305,200 - $511,350	-7,000 Reduced 95.43%	335 $22,000
Q3 2020 Nov 13, 2020	SELL	$38.47 - $52.03 $8,848 - $11,966	-230 Reduced 3.04%	7,335 $377,000

Q2 2020 Aug 14, 2020	SELL	$27.28 - $43.01 $34,645 - $54,622	-1,270 Reduced 14.37%	7,565 $285,000
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $154,289 - $237,518	6,685 Added 310.93%	8,835 $263,000
Q4 2019 Feb 12, 2020	BUY	$15.74 - $35.04 $33,841 - $75,336	2,150 New	2,150 $74,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.